Therapies and Diagnostics for Cervical Cancer

  • Published: August 2013
  • |
  • Report Code: HLC141A

REPORT HIGHLIGHTS

The global cervical cancer market for drugs and diagnostics was $11.3 billion in 2012 and is expected to grow from $11.6 billion in 2013 to $15.6 billion by 2018, a compound annual growth rate (CAGR) of 6.1%.

This report provides:

  • An overview of the global market for cervical cancer diagnostics and therapies.
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • A breakdown of the markets by prophylactics, screening and diagnostics, surgery, radiation therapy, and drug therapy.
  • Discussion of cervical cancer biology.
  • Delineation of drugs approved to treat the disease, including chemotherapeutic and immunotherapeutic.
  • Evaluation of the patent landscape.
  • Comprehensive profiles of key companies.

SAMPLE FIGURE
CERVICAL CANCER: GLOBAL MARKET FOR DRUGS AND DIAGNOSTICS, 2012-2018
($ MILLIONS)
CERVICAL CANCER: GLOBAL MARKET FOR DRUGS AND DIAGNOSTICS, 2012-2018
To Contact us, click here  help


Source: BCC Research

Download Report Overview

REPORT SCOPE

SCOPE OF THE STUDY

The scope of this study includes testing, prophylactics vaccines, screening tests and methods, and therapeutics markets for cervical cancers. The report also discusses current technologies, new technologies, cervical cancer incidence, and market projections and market share, along with latest trends and new developments.

ABOUT THE AUTHOR

Usha Nagavarapu is an experienced pharmaceutical professional with scientific and business development experience. She has managed preclinical discovery programs involving target identification, including investigational new drug (IND) enabling studies, and assisted out-licensing and portfolio development activities. Her strong focus areas include oncology, dermatology, and cardiovascular diseases. She has extensive experience working with early start-ups to fulfill operational obligations while minimizing overall operational cost and burden.


Download Report Overview

REPORT TOC

Pricing on the website is provided for single users and 2-5 users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at (+1)781-489-7301 or send an email to information@bccresearch.com
  Title/Chapter Name Pages Price
Therapies and Diagnostics for Cervical Cancer 211 $3990
Chapter- 1: INTRODUCTION - Complimentary 4 $0
  Show Details
Chapter- 2: SUMMARY 2 $250
  Show Details
Chapter- 3: OVERVIEW 10 $284
  Show Details
Chapter- 4: CERVICAL CANCER: BIOLOGY 13 $369
  Show Details
Chapter- 5: SCREENING 22 $624
  Show Details
Chapter- 6: THE TREATMENT OF CERVICAL CANCER 14 $397
  Show Details
Chapter- 7: CERVICAL CANCER INCIDENCE 49 $1390
  Show Details
Chapter- 8: CERVICAL CANCER DIAGNOSTICS MARKET 32 $908
  Show Details
Chapter- 9: CERVICAL CANCER PROPHYLACTICS MARKET 11 $312
  Show Details
Chapter- 10: THERAPEUTIC MARKET 32 $908
  Show Details
Chapter- 11: PATENT LANDSCAPE 4 $113
  Show Details
Chapter- 12: SELECTED COMPANY PROFILES 9 $255
  Show Details
Chapter- 13: REFERENCES 9 $255
  Show Details
 
  List of Tables
  List of Figures
download report overview
Select License type:

Original Price $6650
Special Price $3990

buy now

Preferred Pricing available for:

  • Startup or Small Business (Revenue <$1M)
  • Academic Institute
  • Government Agency
  • Nonprofit Organization
Get Started
Want to find out more
about this report?
request more info
Get Notified
on all the latest research reports
Subscribe